高危孕妇剖宫产宫缩乏力药物治疗无效时应用改良式Hayman缝合术在预防产后出血中的应用效果观察

Observation on the effect of modified Hayman suture in prevention of postpartum hemorrhage in high-risk pregnant women who failed drug treatment for caesarean section and uterine fatigue

目的探究改良式Hayman缝合术在高危孕妇剖宫产宫缩乏力药物治疗无效时的应用效果。方法选取60例高危孕妇剖宫产宫缩乏力药物治疗无效的患者,按照随机数字表法分为试验组(29例)与对照组(31例)。对照组采用卡前列素氨丁三醇注射液止血治疗,试验组采用改良式Hayman缝合术止血治疗。出院后6个月进行随访,比较两组止血时间、术后24h出血量、术后并发症发生情况、住院时间及出院后月经恢复情况。结果试验组止血时间短于对照组,术后24h出血量少于对照组,差异有统计学意义(P<0.05)。试验组并发症发生率为6.90%,低于对照组32.26%,差异具有统计学意义(P<0.05)。试验组住院时间及出院后月经恢复时间均短于对照组,差异具有统计学意义(P<0.05)。结论改良式Hayman缝合术在高危孕妇剖宫产宫缩乏力药物治疗无效时能够快速止血,降低并发症发生。

Objective To explore the application effect of modified Hayman suture in high-risk pregnant women who failed to respond to drug therapy for caesarean section with uterine fatigue.Methods 60 high-risk pregnant women with weak caesarean section who failed drug treatment were selected as research objects,and divided into experimental group(29 cases)and control group(31 cases)according to random number table.The control group was treated with carprost amine triol hemostasis,and the experimental group was treated with modified Hayman suture hemostasis.Follow-up was conducted 6 months after discharge,and the time of hemostasis,the amount of blood loss 24 h after surgery,the occurrence of postoperative complications,the length of hospital stay and the recovery of menstruation after discharge were compared between the two groups.Results The hemostatic time of experimental group was shorter than that of control group,and the blood loss 24 h after operation was less than that of control group,the difference was statistically significant(P<0.05).The complication rate of experimental group was 6.90%lower than that of control group(32.26%),and the difference was statistically significant(P<0.05).Hospitalization time and menstrual recovery time after discharge of experimental group were shorter than those of control group,the difference was statistically significant(P<0.05).Conclusion Modified Hayman suture can quickly stop bleeding and reduce complications in high-risk pregnant women who failed to respond to drug therapy for caesarean section.